Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HUM.MX
STRONG BUYFLAGHumana Inc. · Healthcare · United States · $24.1B · Avg Vol: $3K/d
Humana has strong momentum at M83 but value at V46 is below the calibrated floor and quality Q53 is thin, so stage one fails.
COMPANY DESCRIPTION
Humana Inc. is a leading U.S. health insurance company, with a dominant focus on government-sponsored programs, particularly Medicare Advantage. The company's competitive advantage is rooted in its scale, deep provider networks, and integrated care delivery model, which includes primary care clinics and home health services. Its specialized focus makes it highly sensitive to federal regulatory and reimbursement policies.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92.9B | 106.4B | 117.8B | 129.7B | 11.8% | 137.2B | 162.3B | 169.9B | 14.5% |
| EPS | 22.20 | 20.09 | 10.01 | 9.87 | -23.7% | 9.40 | — | — | — |
| Shares | 125.0M | 122.2M | 120.6M | 120.6M | -3.5% | 120.1M | — | — | — |
| Debt | 11.1B | 11.7B | 11.7B | 12.4B | 3.6% | 14.4B | — | — | — |
| Equity | 15.3B | 16.3B | 16.4B | 17.7B | 4.9% | — | — | — | — |
| Op CF | 4.6B | 4.0B | 3.0B | 921.0M | -41.4% | 1.8B | — | — | — |
| Inv CF | -1.0B | -3.5B | -3.0B | 2.3B | — | — | — | — | — |
| Fin CF | -1.9B | -856.0M | -2.5B | -1.2B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HUM.MX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HUM.MX | Humana Inc.(you) | $24.1B | 83 | STRONG BUY |
| CNC | Centene Corporation | $31.3B | 92 | STRONG BUY |
| MOH | Molina Healthcare, Inc. | $10.3B | 77 | BUY |
| OSCR | Oscar Health, Inc. | $8.5B | 88 | STRONG BUY |
| ELV | Elevance Health, Inc. | $81.9B | 94 | STRONG BUY |
| CI | The Cigna Group | $76.6B | 97 | STRONG BUY |
| CVS | CVS Health Corporation | $137.5B | 90 | STRONG BUY |
| CLOV | Clover Health Investments, Corp. | $2.3B | 73 | BUY |
| PGNY | Progyny, Inc. | $2.4B | 97 | STRONG BUY |
| UNH | UnitedHealth Group Incorporated | $382.1B | 91 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.9%